Nova Patents
LU92155I2

Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors

Abstract

Enantiomerically pure compound of formula 1 are provided, as well as methods for their synthesis and use. Preferred compounds are potent inhibitors of the c-Met protein kinase, and are useful in the treatment of abnormal cell growth disorders, such as cancers.

Term

6.4 yearsto projected expiry

Projected expiry 20 February 2033, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

80 members in 48 offices

This recordMember, by publication datePriority claim38 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
60508604United States of AmericaP

Members80

Family members, oldest first
DocumentOfficeKind
NL1029799A1Netherlands (Kingdom of the)A1
AU2005276135A1AustraliaA1
CA2578066A1CanadaA1
CA2578066ECanadaE
US2006046991A1United States of AmericaA1
WO2006021884A2World Intellectual Property Organization (WIPO)A2
GT200500225AGuatemalaA
UY29081A1UruguayA1
WO2006021884A3World Intellectual Property Organization (WIPO)A3
PE20060501A1PeruA1
TW200621715ATaiwan Province of ChinaA
PA8643301A1PanamaA1
NL1029799C2Netherlands (Kingdom of the)C2
AR050788A1ArgentinaA1
AP2007003888A0African Regional Intellectual Property Organization (ARIPO)A0
ECSP077276AEcuadorA
KR20070038562ARepublic of KoreaA
MX2007002312AMexicoA
EP1786785A2European Patent Office (EPO)A2
NO20071290LNorwayL
IL181384A0IsraelA0
IL181384D0IsraelD0
CR8860ACosta RicaA
MA28828B1MoroccoB1
CN101023064AChinaA
EA200700352A1Eurasian Patent Organization (EAPO)A1
HK1105414AHong Kong, ChinaA
HK1105414A1Hong Kong, ChinaA1
NI200700057ANicaraguaA
JP2008510790AJapanA
BRPI0513915ABrazilA
TNSN07070A1TunisiaA1
ZA200700127BSouth AfricaB
KR100859891B1Republic of KoreaB1
JP4242911B2JapanB2
UA87153C2UkraineC2
HN2005000476AHondurasA
GEP20104906BGeorgiaB
EP1786785B1European Patent Office (EPO)B1
AT463486TAustriaT
ATE463486T1AustriaT1
DE602005020465D1GermanyD1
PT1786785EPortugalE
DK1786785T3DenmarkT3
ES2341351T3SpainT3
NZ552866ANew ZealandA
EA013678B1Eurasian Patent Organization (EAPO)B1
HRP20100298T1CroatiaT1
SI1786785T1SloveniaT1
PL1786785T3PolandT3
US2010324061A1United States of AmericaA1
US7858643B2United States of AmericaB2
CN101023064BChinaB
ME01788BMontenegroB
RS51362BSerbiaB
AU2005276135B2AustraliaB2
CA2578066CCanadaC
MY145177AMalaysiaA
TWI358406BTaiwan Province of ChinaB
AP2373AAfrican Regional Intellectual Property Organization (ARIPO)A
IL181384AIsraelA
US2012263706A1United States of AmericaA1
LTPA2013005I1LithuaniaI1
FR13C0015I1FranceI1
NO333231B1NorwayB1
LU92155I2This recordLuxembourgI2
NO2013008I1NorwayI1
EP1786785B9European Patent Office (EPO)B9
ES2341351T9SpainT9
FR13C0015I2FranceI2
NO2013008I2NorwayI2
US8785632B2United States of AmericaB2
US2014288086A1United States of AmericaA1
CY1110044T1CyprusT1
CY2013014I1CyprusI1
CY2013014I2CyprusI2
LU92155I9LuxembourgI9
BR122020017756B1BrazilB1
BE2013C021I2BelgiumI2
NO2025046I1NorwayI1